<DOC>
	<DOCNO>NCT01369420</DOCNO>
	<brief_summary>The purpose study evaluate safety feasibility NanoKnife Low Energy Direct Current ( LEDC ) System use treat unresectable pancreatic adenocarcinoma . Safety review mean analysis adverse event , include serious adverse event , laboratory data , physician exam finding , vital sign .</brief_summary>
	<brief_title>NanoKnife Low Energy Direct Current ( LEDC ) System Subjects With Locally Advanced Unresectable Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>1. male female 2 . &gt; /= 18 year age 3. meet criteria locally advanced unresectable pancreatic adenocarcinoma , radiographically proven pancreatic cancer determine surgical oncologist via pancreatic CT initially think resectable ; however time surgery upstaged unresectability , via direct visualization 4. tumor size must &lt; 4 cm must measurable 5. must INR &lt; 1.5 6. must unresponsive chemotherapy demonstrate either CT MR image take chemotherapy agent within 14 day treatment NanoKnife LEDC System 7. willing able comply protocol requirement 8. able comprehend willing sign Informed Consent Form ( ICF ) 1. baseline creatinine report &gt; 2.0 mg/dL 2. report baseline lab value grade 3 4 toxicity define CTCAE Version 3.0 3. inability stop antiplatelet Coumadin therapy 7 day prior 7 day post treatment NanoKnife System 4. know history contrast allergy medically manage 5. know hypersensitivity metal electrode ( stainless steel 304L ) medically manage 6. unable treat muscle blockade agent ( e.g . pancuronium bromide , atracurium , cisatracurium , etc ) 7. woman pregnant currently breast feed 8. woman childbearing potential utilizing acceptable method contraception 9. take investigational agent within 30 day visit 1 10. implanted cardiac pacemaker defibrillator 11. implanted electronic device implant metal part immediate vicinity lesion 12. history epilepsy cardiac arrhythmia ( atrial ventricular fibrillation ) 13. recent history myocardial infarction ( within past 2 month ) 14. QT interval great 550 m unless treat Accysync Model 72 synchronization system control NanoKnife system 's output pulse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>locoregional cancer therapy</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>unresectable pancreatic cancer</keyword>
	<keyword>pancreatic adenocarcinoma</keyword>
	<keyword>locally advanced , unresectable pancreatic cancer</keyword>
	<keyword>pancreatic cancer tumor ablation</keyword>
	<keyword>NanoKnife tumor ablation pancreatic cancer</keyword>
	<keyword>NanoKnife LEDC system tumor ablation</keyword>
	<keyword>Non thermal ablation</keyword>
	<keyword>Irreversible electroporation pancreatic cancer treatment</keyword>
	<keyword>IRE unresectable pancreatic cancer</keyword>
</DOC>